European Pharmaceutical Manufacturer is a well-known brand that keeps readers up to date on the pharma/biopharma manufacturing supply chain, from formulation to distribution, with a focus on important news, innovations, and breakthroughs in this technologically advanced area.
A research report published by Owen Mumford Pharmaceutical Services in late 2019 highlights the rapidly growing commercial potential for biosimilars. This article explores those findings and explains how device design plays a key supporting role, especially as biosimilars continue to gain traction in these markets.